12:00 AM
 | 
Sep 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Xaluprine mercaptopurine regulatory update

The Scottish Medicines Consortium recommended the use of Xaluprine mercaptopurine from Nova on the National Health Service (NHS) in Scotland to treat acute lymphoblastic leukemia (ALL) - its approved...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >